Publication

Article

Oncology Live®

December 2010
Volume11
Issue 12

Technology for the Taking at Research Hub in Scotland

Author(s):

The University of Glasgow will begin offering medical and scientific research findings, including cancer-related discoveries, to businesses and entrepreneurs free of charge

The University of Glasgow will begin offering medical and scientific research findings, including cancer-related discoveries, to businesses and entrepreneurs free of charge as a way to speed up the move of intellectual property (IP) from the academic enclave to the marketplace.

The Scottish institution said it is the first university in the United Kingdom to take such a step, which the school described in a press release as part of its libertarian orientation. The technologies will be offered through a Website, Easy Access IP (www.glasgow. ac.uk/technology).

The cancer-related offerings include a telomerase targeted adenoviral suicide-gene therapy vector that has been tested on ovarian cancer cells and a sensor technology called Lab-in- a-Pill that may be used to detect colorectal cancer.

Related Videos
Kathleen N. Moore, MD, MS
Kathleen N. Moore, MD, MS
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center
Jennifer Scalici, MD
Haley M. Hill, PA-C, discusses preliminary data for zenocutuzumab in NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses how physician assistants aid in treatment planning for NRG1-positive non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses DNA vs RNA sequencing for genetic testing in non–small cell lung cancer and pancreatic cancer.
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Premal Thaker, MD, MS
Aparna Parikh, MD